North Central London Formulary


	North Central London Joint Formulary

Search

Formulary Chapter 11: Eye - Full Chapter

11.08.02

Ocular diagnostic and peri-operative preparations and photodynamic treatment

11.08.02

Ocular diagnostic preparations

11.08.02

Ocular peri-operative drugs

Acetylcholine intra-ocular irrigation
(Miochol-E^®, Miphtel^®)
(Ophthalmic)

Formulary

Provider notes

NMUH:
- No restriction stated
RFL:
- No restriction stated
RNOH:
- Non-formulary
UCLH:
WH:
- No restriction stated

Apraclonidine eye drops (various strengths)
(Iopidine^®)
(Ophthalmic)

Restricted

Provider notes

NMUH:
- Apraclonidine 0.5% used short-term to delay laser treatment or surgery in patients with glaucoma not adequately controlled by another drug
- See link below
RFL:
- 0.5% approved for
  - Short term reduction of elevated IOP
  - Horner’s syndrome test
- 1% approved for
  - Post-laser
  - To low lower IOP in certain circumstances
RNOH:
- Non-formulary
UCLH:
WH:
- Apraclonidine 1% preservative-free is restricted to Ophthalmology

NCL JFC: Open Angle Glaucoma And Ocular Hypertension Glaucoma Prescribing Guideline

Diclofenac sodium 0.1% eye drops - single use
(Ophthalmic)

Restricted

Provider notes

NMUH:
- Non-formulary
RFL:
- Approved for
  - Cataract surgery (Ophthalmologist use only)
  - Post-op inflammation (Ophthalmologist use only)
  - Ocular symptoms in allergic conjunctivitis (Ophthalmologist use only)
RNOH:
- Non-formulary
UCLH:
WH:
- No restriction stated

Ketorolac 0.5% eye drops
(Ophthalmic)

Restricted

Approved for:

Treatment of inflammation post cataract surgery in patients unable to tolerate topical corticosteroids
Prophylaxis of cystoid macular oedema (CMO) in high-risk patients

Provider notes

NMUH:
- Restricted to Consultant Ophthalmologist use only.
RFL:
- Approved for inflammation in anterior segment
RNOH:
- Non-formulary
UCLH:
WH:
- Restricted to ophthalmology

11.08.02

Subfoveal choroidal neovascularisation

11.08.02

Vitreomacular traction

....

Non Formulary Items

Bromfenac 900micrograms/ml eye drops

Non Formulary

Not approved for post-cataract surgery (JFC April 2013)

Not approved for prophylaxis of cystoid macular oedema (CMO) in high-risk patients (JFC April 2013)

Diclofenac Sodium 0.1% eye drops
(Voltarol^® Ophtha multidose)
(Ophthalmic)

Non Formulary

Flurbiprofen 0.03% eye drops
(Ocufen^®)

Non Formulary

Nepafenac eye drops
(Nevanac^®)
(Ophthalmic)

Non Formulary

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

Homecare

Traffic Light Status Information

Status	Description
	Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised. Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC. Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.
	Medicines which should normally be prescribed by specialists only (hospital only). For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care. See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf
	Medicines not recommended for routine use in primary or secondary care. Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.